BBLG Insider Trading

Insider Ownership Percentage: 13.00%
Insider Buying (Last 12 Months): $21,658.24
Insider Selling (Last 12 Months): $0.00

Bone Biologics Insider Trading History Chart

This chart shows the insider buying and selling history at Bone Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bone Biologics Share Price & Price History

Current Price: $1.20
Price Change: Price Increase of +0.09 (8.11%)
As of 07/22/2024 01:00 AM ET

This chart shows the closing price history over time for BBLG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Bone Biologics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2023Deina H WalshCFOBuy1,000$5.12$5,120.001,875View SEC Filing Icon  
9/11/2023Jeff FrelickCEOBuy1,187$5.52$6,552.242,150View SEC Filing Icon  
9/6/2023Deina H WalshCFOBuy875$5.68$4,970.00875View SEC Filing Icon  
8/31/2023Jeff FrelickCEOBuy950$5.28$5,016.00963View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Bone Biologics (NASDAQ:BBLG)

34.30% of Bone Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bone Biologics logo
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Read More on Bone Biologics

Today's Range

Now: $1.20
Low: $1.07
High: $1.21

50 Day Range

MA: $1.44
Low: $1.10
High: $2.30

52 Week Range

Now: $1.20
Low: $1.00
High: $12.24

Volume

27,676 shs

Average Volume

96,007 shs

Market Capitalization

$1.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Bone Biologics?

Bone Biologics' top insider shareholders include:
  1. Jeff Frelick (CEO)
  2. Deina H Walsh (CFO)
Learn More about top insider investors at Bone Biologics.